Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

CRNX

Crinetics Pharmaceuticals, Inc.

Healthcare · Pharmaceutical Preparations

$84.95Aug 31, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

Crinetics Pharmaceuticals, Inc. shows accelerating business momentum based on AlphaOS pipeline evidence.

TrajectoryAccelerating

3 signals not yet derived from pipeline evidence

Pipeline evidence · 0d ago

CRNX's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on CRNX.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest Intelligence

Updated

What happened recently for Crinetics Pharmaceuticals, Inc. (CRNX) — events, not interpretation.

Event
Last session August 31, 2026 at $84.95.
Source
Market data

Research & analysis only — not investment advice.

Building company intelligence…

Crinetics Pharmaceuticals, Inc. (CRNX)

Healthcare · Pharmaceutical Preparations

Investment Snapshot above is the primary AlphaOS analysis for Crinetics Pharmaceuticals, Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Market cap:
$9.01B
Revenue:
$25.12M

CRNX earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Crinetics Pharmaceuticals, Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.